Patient Assistance Introduction

This page includes resources for health care professionals to share with patients using REMICADE® (infliximab) and their family members and caregivers. Please click on any of the links below to get more detailed information.

Open Enrollment Brochure. Even if patients keep the same health plan, benefits can change. The information in the Open Enrollment brochure can help patients make sure they have the coverage needed beginning January 1.

Medicare Resource Guide. This guide can help patients understand how Medicare may cover their care, including medications they may need.

REMICADE® Patient Insurance Information Request Form. Click here to view and print the REMICADE® Patient Insurance Information Request Form.

Janssen Prescription Assistance for REMICADE® (infliximab). This page has information about prescription assistance programs sponsored by relevant Janssen Pharmaceutical Companies as well as up-to-date information about independent foundations that may have available funding to help minimize drug costs for REMICADE®.

Johnson & Johnson Patient Assistance Foundation. Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF) is committed to providing access to medicines for uninsured individuals who lack the financial resources to pay for them. If your patient needs REMICADE® (infliximab), and is uninsured and unable to pay for their medicine, please have them contact a JJPAF program specialist at 1-800-652-6227 9 AM to 6 PM ET or visit the foundation website at to see if they might qualify for assistance.

RemiStart®. RemiStart® is a patient rebate program that supports your access to REMICADE® (infliximab). Based on your eligibility, RemiStart® can provide a rebate for your medication out-of-pocket costs, including deductible, co-payment, and co-insurance. If eligible, you will be responsible for $5 per infusion and will receive a rebate for the remaining medication out-of-pocket costs, with up to $20,000 maximum program benefit per calendar year. This program is only available to individuals using private or commercial health insurance to cover a portion of their medications costs, including plans available through state and federal healthcare exchanges. To enroll, patients should submit a completed enrollment form (editable) to RemiStart®. Click to view the full patient brochure and Medication Guide. For additional information, including eligibility and restrictions, please visit or click to view the RemiStart Flashcard.

Patient Support Links. This section of the site has a list of other web resources to help your patients and their families understand and manage therapy with REMICADE® and their disease.

March 25, 2016